Original ArticleInduction Chemotherapy with Carboplatin, Irinotecan, and Paclitaxel Followed by High Dose Three-Dimension Conformal Thoracic Radiotherapy (74 Gy) with Concurrent Carboplatin, Paclitaxel, and Gefitinib in Unresectable Stage IIIA and Stage IIIB Non-small Cell Lung Cancer
Under an Elsevier user license
open archive
Key Words
High-dose radiation
Combined modality therapy
Conformal radiation therapy
Epidermal growth factor receptor
Tyrosine kinase inhibitor
Concurrent chemoradiotherapy
Cited by (0)
The first two authors contributed equally to this article.
This trial was an investigator-initiated trial supported by Astra-Zeneca and Amgen.
Disclosure: Mark A. Socinski has received research funding from Astra-Zeneca. Dr. Socinski and the other authors have no other conflicts of interest to declare.
Copyright © 2008 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.